AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

Ailawadhi S, Parrondo RD, Dutta N, Han B, Ciccio G, Cherukuri Y, Alegria VR, LaPlant BR, Roy V, Sher T, Edwards B, Lanier S, Manna A, Heslop K, Caulfield T, Maldosevic E, Storz P, Manochakian R, Asmann Y, Chanan-Khan AA, Paulus A

Open source

DOI: 10.3390/cancers15020477
Published: 2023 Jan 12
Container: Cancers
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers15020477,
  title = {AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.},
  author = {Ailawadhi S and Parrondo RD and Dutta N and Han B and Ciccio G and Cherukuri Y and Alegria VR and LaPlant BR and Roy V and Sher T and Edwards B and Lanier S and Manna A and Heslop K and Caulfield T and Maldosevic E and Storz P and Manochakian R and Asmann Y and Chanan-Khan AA and Paulus A},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15020477},
  url = {https://doi.org/10.3390/cancers15020477}
}

RIS

TY  - JOUR
TI  - AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.
AU  - Ailawadhi S
AU  - Parrondo RD
AU  - Dutta N
AU  - Han B
AU  - Ciccio G
AU  - Cherukuri Y
AU  - Alegria VR
AU  - LaPlant BR
AU  - Roy V
AU  - Sher T
AU  - Edwards B
AU  - Lanier S
AU  - Manna A
AU  - Heslop K
AU  - Caulfield T
AU  - Maldosevic E
AU  - Storz P
AU  - Manochakian R
AU  - Asmann Y
AU  - Chanan-Khan AA
AU  - Paulus A
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15020477
UR  - https://doi.org/10.3390/cancers15020477
ER  -

APA

S, A., RD, P., N, D., B, H., G, C., Y, C., VR, A., BR, L., V, R., T, S., B, E., S, L., A, M., K, H., T, C., E, M., P, S., R, M., Y, A., AA, C., & A, P. (2023). AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.. Cancers. https://doi.org/10.3390/cancers15020477

Source records

pubmed · retrieved 2026-11-10T14:25:29.058Z
europe-pmc · retrieved 2026-11-10T14:25:29.071Z